A subgroup analysis showed that epcoritamab is effective regardless of CAR T–exposure in patients with R/R LBCL.

SAN DIEGO -- Children with newly diagnosed B-cell acute lymphoblastic leukemia (B-ALL) lived significantly longer without ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/91.IM06wodO.js ...

School index scores for Traverse City Area Public Schools disclose modest growth for some schools, but a significant drop for ...

With a positive phase 3 trial in chronic lymphocytic leukemia (CLL), Eli Lilly hopes to convert Jaypirca’s unique accelerated ...

The Scottish Offshore Wind Energy Council (SOWEC) has appointed Mark Baxter and Stewart McKinlay to chair its developer forum ...

Unveiling the power of AI in patient subgroups SOMS' AI-driven subgroup analysis is transforming clinical trials through real-time data processing and continuous tracking of patient subgroups.

Developments in chronic lymphocytic leukemia (CLL) this year included the first CAR T-cell therapy approval for the chronic ...

Elritercept demonstrated a durable transfusion independence in lower-risk myelodysplastic syndromes, including in patients with high transfusion ...

This study makes a valuable advance in our understanding of defensive symbionts in insects. It uses a meta-analysis to quantify the magnitude of change in host fitness components when symbionts are ...

SHR-A1811 showed promising antitumor activity and acceptable tolerability in patients with HER2-positive breast cancer, ...

Research shows 3.4 minutes of daily VILPA is associated with a 45% reduction in major adverse cardiovascular events, ...